speb/financial-data huggingface dataset:
PACS income_statement (quarterly, 2025-06-30) — Selling General And Administration: 100332000.00
PACS balance_sheet (quarterly, 2025-06-30) — Share Issued: 156569693.00
PACS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
PACS cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 13604000.00
PACS balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 806840000.00
PACS balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 739779000.00
PACS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
PACS income_statement (quarterly, 2025-06-30) — Tax Provision: 27646000.00
PACS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.35
PACS balance_sheet (quarterly, 2025-06-30) — Total Assets: 5502169000.00
PACS balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 1053832000.00
PACS balance_sheet (quarterly, 2025-06-30) — Total Debt: 3535587000.00
PACS balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 812668000.00
PACS income_statement (quarterly, 2025-06-30) — Total Expenses: 1228737000.00
PACS balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 4689501000.00
PACS balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 4424948000.00
PACS balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 3522270000.00
PACS income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 80499000.00
PACS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
PACS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
PACS balance_sheet (quarterly, 2025-06-30) — Working Capital: -90010000.00
PACS income_statement (quarterly, 2025-09-30) — +Operating Expense: 116929000.00
PACS income_statement (quarterly, 2025-09-30) — +Total Revenue: 1344567000.00
PACS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 205479000.00
PACS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 628280000.00
PACS balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -145108000.00
PACS balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 621288000.00
PACS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 156575127.00
PACS income_statement (quarterly, 2025-09-30) — Basic EPS: 0.33
PACS cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 297642000.00
PACS balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 734136000.00
PACS cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -98361000.00
PACS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 3113650000.00
PACS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 157000.00
PACS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 355672000.00
PACS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 355672000.00
PACS cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: 0.00
PACS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -46324000.00
PACS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -97058000.00
PACS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 204796000.00
PACS cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 31807000.00
PACS cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 1133000.00
PACS cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 6842000.00
PACS cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 77203000.00
PACS cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -1012000.00
PACS cash_flow (quarterly, 2025-09-30) — Change In Payable: 31807000.00
PACS cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 32940000.00
PACS cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 16873000.00
PACS cash_flow (quarterly, 2025-09-30) — Change In Receivables: -4936000.00
PACS cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 127910000.00
PACS cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 9847000.00
PACS cash_flow (quarterly, 2025-09-30) — Changes In Cash: 61414000.00
PACS balance_sheet (quarterly, 2025-09-30) — Common Stock: 157000.00
PACS cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: 0.00
PACS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 871322000.00
PACS cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
PACS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 30998000.00
PACS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 1141369000.00
PACS balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 552884000.00
PACS balance_sheet (quarterly, 2025-09-30) — Current Assets: 1126749000.00
PACS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 150651000.00
PACS balance_sheet (quarterly, 2025-09-30) — Current Debt: 107474000.00
PACS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 258125000.00
PACS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 1197621000.00
PACS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 181133000.00
PACS cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -14508000.00
PACS cash_flow (quarterly, 2025-09-30) — Deferred Tax: -14508000.00
PACS cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 14401000.00
PACS income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 14401000.00
PACS cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 14401000.00
PACS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 14401000.00
PACS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 164709367.00
PACS income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.32
PACS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 52406000.00
PACS cash_flow (quarterly, 2025-09-30) — Dividends Received Cfi: 1354000.00
PACS income_statement (quarterly, 2025-09-30) — EBIT: 84825000.00
PACS income_statement (quarterly, 2025-09-30) — EBITDA: 99226000.00
PACS cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: 488000.00
PACS cash_flow (quarterly, 2025-09-30) — End Cash Position: 359056000.00
PACS cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -46324000.00
PACS cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 106435000.00
PACS cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of Business: -1140000.00
PACS income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 102528000.00
PACS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 68061000.00
PACS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 4279383000.00
PACS income_statement (quarterly, 2025-09-30) — Gross Profit: 203198000.00
PACS cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 625000.00
PACS income_statement (quarterly, 2025-09-30) — Interest Expense: 8529000.00
PACS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 8529000.00
PACS cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 10639000.00
PACS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 1224699000.00
PACS cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -97058000.00
PACS cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
PACS cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
PACS balance_sheet (quarterly, 2025-09-30) — Land And Improvements: 89478000.00
PACS balance_sheet (quarterly, 2025-09-30) — Leases: 108224000.00
PACS balance_sheet (quarterly, 2025-09-30) — Line Of Credit: 100000000.00
PACS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 2962999000.00
PACS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 245903000.00
PACS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 3208902000.00
PACS cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 0.00
PACS cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -45726000.00
PACS balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 124414000.00
PACS balance_sheet (quarterly, 2025-09-30) — Minority Interest: 5594000.00
PACS income_statement (quarterly, 2025-09-30) — Minority Interests: 76000.00
PACS cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
PACS cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
PACS income_statement (quarterly, 2025-09-30) — Net Income: 52406000.00
PACS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 52406000.00
PACS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 52330000.00
PACS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 52406000.00
PACS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 52406000.00
PACS cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 52330000.00
PACS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 52330000.00
PACS income_statement (quarterly, 2025-09-30) — Net Interest Income: -8529000.00
PACS cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -51000.00
PACS cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -45726000.00
PACS cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -45726000.00
PACS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -8529000.00
PACS cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -598000.00
PACS balance_sheet (quarterly, 2025-09-30) — Net PPE: 4134275000.00
PACS cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -98361000.00
PACS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 803261000.00
PACS balance_sheet (quarterly, 2025-09-30) — Non Current Accrued Expenses: 177480000.00
PACS balance_sheet (quarterly, 2025-09-30) — Non Current Prepaid Assets: 80300000.00
PACS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 99226000.00
PACS income_statement (quarterly, 2025-09-30) — Normalized Income: 52406000.00
PACS cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 204796000.00
PACS cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -652000.00
PACS income_statement (quarterly, 2025-09-30) — Operating Income: 86269000.00
PACS income_statement (quarterly, 2025-09-30) — Operating Revenue: 1344302000.00
PACS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 156615144.00
PACS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 76369000.00
PACS balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 7474000.00
PACS income_statement (quarterly, 2025-09-30) — Other Gand A: 102528000.00
PACS income_statement (quarterly, 2025-09-30) — Other Income Expense: -1444000.00
PACS cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 12799000.00
PACS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 217507000.00
PACS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 165973000.00
PACS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -1444000.00
PACS balance_sheet (quarterly, 2025-09-30) — Other Properties: 3192133000.00
PACS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 66428000.00
PACS balance_sheet (quarterly, 2025-09-30) — Payables: 205479000.00
PACS balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 758363000.00
PACS income_statement (quarterly, 2025-09-30) — Pretax Income: 76296000.00
PACS balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
PACS cash_flow (quarterly, 2025-09-30) — Purchase Of Business: 0.00
PACS cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -51000.00
PACS cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -98361000.00
PACS balance_sheet (quarterly, 2025-09-30) — Receivables: 694708000.00
PACS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 1141369000.00
PACS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 14401000.00
PACS income_statement (quarterly, 2025-09-30) — Rent Expense Supplemental: 95107000.00
PACS cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -45726000.00
PACS balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 249877000.00
PACS income_statement (quarterly, 2025-09-30) — Selling General And Administration: 102528000.00
PACS balance_sheet (quarterly, 2025-09-30) — Share Issued: 156615144.00
PACS income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
PACS cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 12516000.00
PACS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 871322000.00
PACS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 803261000.00
PACS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
PACS income_statement (quarterly, 2025-09-30) — Tax Provision: 23966000.00
PACS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.31
PACS balance_sheet (quarterly, 2025-09-30) — Total Assets: 5626892000.00
PACS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 1117225000.00
PACS balance_sheet (quarterly, 2025-09-30) — Total Debt: 3467027000.00
PACS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 876916000.00
PACS income_statement (quarterly, 2025-09-30) — Total Expenses: 1258298000.00
PACS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 4749976000.00
PACS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 4500143000.00
PACS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 3552355000.00
PACS income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 86269000.00
PACS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
PACS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
PACS balance_sheet (quarterly, 2025-09-30) — Working Capital: -70872000.00
PACS income_statement (annual, 2025-12-31) — +Operating Expense: 470733000.00
PACS income_statement (quarterly, 2025-12-31) — +Operating Expense: 128870000.00
PACS income_statement (annual, 2025-12-31) — +Total Revenue: 5288932000.00
PACS income_statement (quarterly, 2025-12-31) — +Total Revenue: 1357979000.00
PACS balance_sheet (annual, 2025-12-31) — Accounts Payable: 192232000.00
PACS balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 192232000.00
PACS balance_sheet (annual, 2025-12-31) — Accounts Receivable: 628128000.00
PACS balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 628128000.00
PACS balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -154166000.00
PACS balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -154166000.00
PACS balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 637035000.00
PACS balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 637035000.00
PACS income_statement (annual, 2025-12-31) — Basic Average Shares: 156180786.00
PACS income_statement (annual, 2025-12-31) — Basic EPS: 1.23
PACS cash_flow (annual, 2025-12-31) — Beginning Cash Position: 160842000.00
PACS cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 359056000.00
PACS balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 823490000.00
PACS balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 823490000.00
PACS cash_flow (annual, 2025-12-31) — Capital Expenditure: -249156000.00
PACS cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -114263000.00
PACS balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 3121855000.00
PACS balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 3121855000.00
PACS balance_sheet (annual, 2025-12-31) — Capital Stock: 157000.00
PACS balance_sheet (quarterly, 2025-12-31) — Capital Stock: 157000.00
PACS balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 197016000.00
PACS balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 197016000.00
PACS balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 197016000.00
PACS balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 197016000.00
PACS cash_flow (annual, 2025-12-31) — Cash Dividends Paid: 0.00
PACS cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: 0.00
PACS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -68990000.00
PACS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -5469000.00
PACS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -264025000.00
PACS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -118146000.00
PACS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 404224000.00
PACS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -3390000.00
PACS cash_flow (annual, 2025-12-31) — Change In Account Payable: 14856000.00
PACS cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -12211000.00
PACS cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 134829000.00
PACS cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -66281000.00
PACS cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -2660000.00
PACS cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 5024000.00
PACS cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -25936000.00
PACS cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 17580000.00
PACS cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 6718000.00
PACS cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 6014000.00
PACS cash_flow (annual, 2025-12-31) — Change In Payable: 14856000.00
PACS cash_flow (quarterly, 2025-12-31) — Change In Payable: -12211000.00
PACS cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 149685000.00
PACS cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -78492000.00
PACS cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -69523000.00
PACS cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -62560000.00
PACS cash_flow (annual, 2025-12-31) — Change In Receivables: 14428000.00
PACS cash_flow (quarterly, 2025-12-31) — Change In Receivables: -7385000.00
PACS cash_flow (annual, 2025-12-31) — Change In Working Capital: 72712000.00
PACS cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -119819000.00
PACS cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 13647000.00
PACS cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 152000.00
PACS cash_flow (annual, 2025-12-31) — Changes In Cash: 71209000.00
PACS cash_flow (quarterly, 2025-12-31) — Changes In Cash: -127005000.00
PACS balance_sheet (annual, 2025-12-31) — Common Stock: 157000.00
PACS balance_sheet (quarterly, 2025-12-31) — Common Stock: 157000.00
PACS cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: 0.00
PACS cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: 0.00
PACS balance_sheet (annual, 2025-12-31) — Common Stock Equity: 946771000.00
PACS balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 946771000.00
PACS cash_flow (annual, 2025-12-31) — Common Stock Issuance: 0.00
PACS cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
PACS balance_sheet (annual, 2025-12-31) — Construction In Progress: 24565000.00
PACS balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 24565000.00
PACS income_statement (annual, 2025-12-31) — Cost Of Revenue: 4508604000.00
PACS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 1134422000.00
PACS balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 441605000.00
PACS balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 441605000.00
PACS balance_sheet (annual, 2025-12-31) — Current Assets: 1069739000.00
PACS balance_sheet (quarterly, 2025-12-31) — Current Assets: 1069739000.00
PACS balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 182001000.00
PACS balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 182001000.00
PACS balance_sheet (annual, 2025-12-31) — Current Debt: 4463000.00
PACS balance_sheet (quarterly, 2025-12-31) — Current Debt: 4463000.00
PACS balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 186464000.00
PACS balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 186464000.00
PACS balance_sheet (annual, 2025-12-31) — Current Liabilities: 1001430000.00
PACS balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 1001430000.00
PACS balance_sheet (annual, 2025-12-31) — Current Provisions: 181129000.00
PACS balance_sheet (quarterly, 2025-12-31) — Current Provisions: 181129000.00
PACS cash_flow (annual, 2025-12-31) — Deferred Income Tax: -17733000.00
PACS cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 13804000.00
PACS cash_flow (annual, 2025-12-31) — Deferred Tax: -17733000.00
PACS cash_flow (quarterly, 2025-12-31) — Deferred Tax: 13804000.00
PACS cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 55663000.00
PACS cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 15379000.00
PACS income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 55663000.00
PACS income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 15379000.00
PACS cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 55663000.00
PACS cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 15379000.00
PACS income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 55663000.00
PACS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 15379000.00
PACS income_statement (annual, 2025-12-31) — Diluted Average Shares: 156700339.00
PACS income_statement (annual, 2025-12-31) — Diluted EPS: 1.22
PACS income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 191543000.00
PACS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 59702000.00
PACS cash_flow (annual, 2025-12-31) — Dividends Received Cfi: 5593000.00
PACS cash_flow (quarterly, 2025-12-31) — Dividends Received Cfi: 1417000.00
PACS income_statement (annual, 2025-12-31) — EBIT: 312813000.00
PACS income_statement (quarterly, 2025-12-31) — EBIT: 95388000.00
PACS income_statement (annual, 2025-12-31) — EBITDA: 368476000.00
PACS income_statement (quarterly, 2025-12-31) — EBITDA: 110767000.00
PACS cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: 773000.00
PACS cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: -27000.00
PACS cash_flow (annual, 2025-12-31) — End Cash Position: 232051000.00
PACS cash_flow (quarterly, 2025-12-31) — End Cash Position: 232051000.00
PACS cash_flow (annual, 2025-12-31) — Financing Cash Flow: -68990000.00
PACS cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -5469000.00
PACS cash_flow (annual, 2025-12-31) — Free Cash Flow: 155068000.00
PACS cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -117653000.00
PACS cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of Business: -4896000.00
PACS cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of Business: -892000.00
PACS income_statement (annual, 2025-12-31) — General And Administrative Expense: 415070000.00
PACS income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 113491000.00
PACS balance_sheet (annual, 2025-12-31) — Goodwill: 61791000.00
PACS balance_sheet (quarterly, 2025-12-31) — Goodwill: 61791000.00
PACS balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 68061000.00
PACS balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 68061000.00
PACS balance_sheet (annual, 2025-12-31) — Gross PPE: 4323438000.00
PACS balance_sheet (quarterly, 2025-12-31) — Gross PPE: 4323438000.00
PACS income_statement (annual, 2025-12-31) — Gross Profit: 780328000.00
PACS income_statement (quarterly, 2025-12-31) — Gross Profit: 223557000.00
PACS cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 84047000.00
PACS cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 3003000.00
PACS income_statement (annual, 2025-12-31) — Interest Expense: 28363000.00
PACS income_statement (quarterly, 2025-12-31) — Interest Expense: 8576000.00
PACS income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 28363000.00
PACS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 8576000.00
PACS cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 40509000.00
PACS cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 11911000.00
PACS balance_sheet (annual, 2025-12-31) — Invested Capital: 1296037000.00
PACS balance_sheet (quarterly, 2025-12-31) — Invested Capital: 1296037000.00
PACS cash_flow (annual, 2025-12-31) — Investing Cash Flow: -264025000.00
PACS cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -118146000.00
PACS cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 0.00
PACS cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
PACS cash_flow (annual, 2025-12-31) — Issuance Of Debt: 0.00
PACS cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
PACS balance_sheet (annual, 2025-12-31) — Land And Improvements: 94024000.00
PACS balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 94024000.00
PACS balance_sheet (annual, 2025-12-31) — Leases: 125832000.00
PACS balance_sheet (quarterly, 2025-12-31) — Leases: 125832000.00
PACS balance_sheet (annual, 2025-12-31) — Line Of Credit: 0.00
PACS balance_sheet (quarterly, 2025-12-31) — Line Of Credit: 0.00
PACS balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 2939854000.00
PACS balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 2939854000.00
PACS balance_sheet (annual, 2025-12-31) — Long Term Debt: 344803000.00
PACS balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 344803000.00
PACS balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 3284657000.00
PACS balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 3284657000.00
PACS cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 0.00
PACS cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
PACS cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -60218000.00
PACS cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -5470000.00
PACS balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 131812000.00
PACS balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 131812000.00
PACS balance_sheet (annual, 2025-12-31) — Minority Interest: 5678000.00
PACS balance_sheet (quarterly, 2025-12-31) — Minority Interest: 5678000.00
PACS income_statement (annual, 2025-12-31) — Minority Interests: 82000.00
PACS income_statement (quarterly, 2025-12-31) — Minority Interests: -83000.00
PACS cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 0.00
PACS cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00
PACS cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 0.00
PACS cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
PACS balance_sheet (annual, 2025-12-31) — Net Debt: 152250000.00
PACS balance_sheet (quarterly, 2025-12-31) — Net Debt: 152250000.00
PACS income_statement (annual, 2025-12-31) — Net Income: 191543000.00
PACS income_statement (quarterly, 2025-12-31) — Net Income: 59702000.00
PACS income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 191543000.00
PACS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 59702000.00
PACS income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 191461000.00
PACS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 59785000.00
PACS income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 191543000.00
PACS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 59702000.00
PACS income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 191543000.00
PACS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 59702000.00
PACS cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 191461000.00
PACS cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 59785000.00
PACS income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 191461000.00
PACS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 59785000.00
PACS income_statement (annual, 2025-12-31) — Net Interest Income: -28363000.00
PACS income_statement (quarterly, 2025-12-31) — Net Interest Income: -8576000.00
PACS cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -21212000.00
PACS cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -6050000.00
PACS cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -60218000.00
PACS cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -5470000.00
PACS cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -60218000.00
PACS cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -5470000.00
PACS income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -28363000.00
PACS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -8576000.00
PACS cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -8772000.00
PACS cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 1000.00
PACS cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 750000.00
PACS balance_sheet (annual, 2025-12-31) — Net PPE: 4169272000.00
PACS balance_sheet (quarterly, 2025-12-31) — Net PPE: 4169272000.00
PACS cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -249156000.00
PACS cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -114263000.00
PACS balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 878710000.00
PACS balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 878710000.00
PACS balance_sheet (annual, 2025-12-31) — Non Current Accrued Expenses: 192561000.00
PACS balance_sheet (quarterly, 2025-12-31) — Non Current Accrued Expenses: 192561000.00
PACS balance_sheet (annual, 2025-12-31) — Non Current Prepaid Assets: 87192000.00
PACS balance_sheet (quarterly, 2025-12-31) — Non Current Prepaid Assets: 87192000.00
PACS income_statement (annual, 2025-12-31) — Normalized EBITDA: 368476000.00
PACS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 110767000.00
PACS income_statement (annual, 2025-12-31) — Normalized Income: 191543000.00
PACS income_statement (quarterly, 2025-12-31) — Normalized Income: 59702000.00
PACS cash_flow (annual, 2025-12-31) — Operating Cash Flow: 404224000.00
PACS cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -3390000.00
PACS cash_flow (annual, 2025-12-31) — Operating Gains Losses: -4123000.00
PACS cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -919000.00
PACS income_statement (annual, 2025-12-31) — Operating Income: 309595000.00
PACS income_statement (quarterly, 2025-12-31) — Operating Income: 94687000.00
PACS income_statement (annual, 2025-12-31) — Operating Revenue: 5287885000.00
PACS income_statement (quarterly, 2025-12-31) — Operating Revenue: 1357717000.00
PACS balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 156615144.00
PACS balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 156615144.00
PACS balance_sheet (annual, 2025-12-31) — Other Current Assets: 170630000.00
PACS balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 170630000.00
PACS balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 4463000.00
PACS balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 4463000.00
PACS income_statement (annual, 2025-12-31) — Other Gand A: 415070000.00
PACS income_statement (quarterly, 2025-12-31) — Other Gand A: 113491000.00
PACS income_statement (annual, 2025-12-31) — Other Income Expense: 3218000.00
PACS income_statement (quarterly, 2025-12-31) — Other Income Expense: 701000.00
PACS balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 6270000.00
PACS balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 6270000.00
PACS cash_flow (annual, 2025-12-31) — Other Non Cash Items: 52175000.00
PACS cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 12633000.00
PACS balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 189770000.00
PACS balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 189770000.00
PACS balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 152937000.00
PACS balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 152937000.00
PACS income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 3218000.00
PACS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 701000.00
PACS balance_sheet (annual, 2025-12-31) — Other Properties: 3123715000.00
PACS balance_sheet (quarterly, 2025-12-31) — Other Properties: 3123715000.00
PACS balance_sheet (annual, 2025-12-31) — Other Receivables: 73965000.00
PACS balance_sheet (quarterly, 2025-12-31) — Other Receivables: 73965000.00
PACS balance_sheet (annual, 2025-12-31) — Payables: 192232000.00
PACS balance_sheet (quarterly, 2025-12-31) — Payables: 192232000.00
PACS balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 633837000.00
PACS balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 633837000.00
PACS income_statement (annual, 2025-12-31) — Pretax Income: 284450000.00
PACS income_statement (quarterly, 2025-12-31) — Pretax Income: 86812000.00
PACS balance_sheet (annual, 2025-12-31) — Properties: 0.00
PACS balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
PACS cash_flow (annual, 2025-12-31) — Purchase Of Business: 0.00
PACS cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 0.00
PACS cash_flow (annual, 2025-12-31) — Purchase Of Investment: -21212000.00
PACS cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -6050000.00
PACS cash_flow (annual, 2025-12-31) — Purchase Of PPE: -249156000.00
PACS cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -114263000.00
PACS balance_sheet (annual, 2025-12-31) — Receivables: 702093000.00
PACS balance_sheet (quarterly, 2025-12-31) — Receivables: 702093000.00
PACS income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 4508604000.00
PACS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 1134422000.00
PACS income_statement (annual, 2025-12-31) — Reconciled Depreciation: 55663000.00
PACS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 15379000.00
PACS income_statement (annual, 2025-12-31) — Rent Expense Supplemental: 378908000.00
PACS income_statement (quarterly, 2025-12-31) — Rent Expense Supplemental: 95658000.00
PACS cash_flow (annual, 2025-12-31) — Repayment Of Debt: -60218000.00
PACS cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -5470000.00
PACS balance_sheet (annual, 2025-12-31) — Retained Earnings: 309579000.00
PACS balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 309579000.00
PACS cash_flow (annual, 2025-12-31) — Sale Of Investment: 0.00
PACS income_statement (annual, 2025-12-31) — Selling General And Administration: 415070000.00
PACS income_statement (quarterly, 2025-12-31) — Selling General And Administration: 113491000.00
PACS balance_sheet (annual, 2025-12-31) — Share Issued: 156615144.00
PACS balance_sheet (quarterly, 2025-12-31) — Share Issued: 156615144.00
PACS income_statement (annual, 2025-12-31) — Special Income Charges: 0.00
PACS income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
PACS cash_flow (annual, 2025-12-31) — Stock Based Compensation: 54069000.00
PACS cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 15747000.00
PACS balance_sheet (annual, 2025-12-31) — Stockholders Equity: 946771000.00
PACS balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 946771000.00
PACS balance_sheet (annual, 2025-12-31) — Tangible Book Value: 878710000.00
PACS balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 878710000.00
PACS income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
PACS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
PACS income_statement (annual, 2025-12-31) — Tax Provision: 92989000.00
PACS income_statement (quarterly, 2025-12-31) — Tax Provision: 27027000.00
PACS income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.33
PACS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.31
PACS balance_sheet (annual, 2025-12-31) — Total Assets: 5584034000.00
PACS balance_sheet (quarterly, 2025-12-31) — Total Assets: 5584034000.00
PACS balance_sheet (annual, 2025-12-31) — Total Capitalization: 1291574000.00
PACS balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 1291574000.00
PACS balance_sheet (annual, 2025-12-31) — Total Debt: 3471121000.00
PACS balance_sheet (quarterly, 2025-12-31) — Total Debt: 3471121000.00
PACS balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 952449000.00
PACS balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 952449000.00
PACS income_statement (annual, 2025-12-31) — Total Expenses: 4979337000.00
PACS income_statement (quarterly, 2025-12-31) — Total Expenses: 1263292000.00
PACS balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 4631585000.00
PACS balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 4631585000.00
PACS balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 4514295000.00
PACS balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 4514295000.00
PACS balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 3630155000.00
PACS balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 3630155000.00
PACS income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 309595000.00
PACS income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 94687000.00
PACS income_statement (annual, 2025-12-31) — Total Unusual Items: 0.00
PACS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
PACS income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
PACS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
PACS balance_sheet (annual, 2025-12-31) — Working Capital: 68309000.00
PACS balance_sheet (quarterly, 2025-12-31) — Working Capital: 68309000.00
PACS income_statement (quarterly, 2026-03-31) — +Operating Expense: 130392000.00
PACS income_statement (quarterly, 2026-03-31) — +Total Revenue: 1420494000.00
PACS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 180662000.00
PACS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 648037000.00
PACS balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -170687000.00
PACS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 646738000.00
PACS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 157073382.00
PACS income_statement (quarterly, 2026-03-31) — Basic EPS: 0.51
PACS cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 232051000.00
PACS balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 901258000.00
PACS cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -108348000.00
PACS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 3072168000.00
PACS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 157000.00
PACS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 247981000.00
PACS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 247981000.00
PACS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -67714000.00
PACS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -126961000.00
PACS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 236335000.00
PACS cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -13932000.00
PACS cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: 95095000.00
PACS cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -3608000.00
PACS cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -5635000.00
PACS cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 144000.00
PACS cash_flow (quarterly, 2026-03-31) — Change In Payable: -13932000.00
PACS cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 81163000.00
PACS cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 77201000.00
PACS cash_flow (quarterly, 2026-03-31) — Change In Receivables: -31127000.00
PACS cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 118138000.00
PACS cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -19909000.00
PACS cash_flow (quarterly, 2026-03-31) — Changes In Cash: 41660000.00
PACS balance_sheet (quarterly, 2026-03-31) — Common Stock: 157000.00
PACS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 1037169000.00
PACS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 32143000.00
PACS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 1170067000.00
PACS balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 519462000.00
PACS balance_sheet (quarterly, 2026-03-31) — Current Assets: 1068105000.00
PACS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 183885000.00
PACS balance_sheet (quarterly, 2026-03-31) — Current Debt: 8385000.00
PACS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 192270000.00
PACS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 1073523000.00
PACS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 181129000.00
PACS cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -12461000.00
PACS cash_flow (quarterly, 2026-03-31) — Deferred Tax: -12461000.00
PACS cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 18077000.00
PACS income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 18077000.00
PACS cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 18077000.00
PACS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 18077000.00
PACS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 162080007.00
PACS income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.50
PACS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 80695000.00
PACS cash_flow (quarterly, 2026-03-31) — Dividends Received Cfi: 1437000.00
PACS income_statement (quarterly, 2026-03-31) — EBIT: 120160000.00
PACS income_statement (quarterly, 2026-03-31) — EBITDA: 138237000.00
PACS cash_flow (quarterly, 2026-03-31) — Earnings Losses From Equity Investments: -455000.00
PACS cash_flow (quarterly, 2026-03-31) — End Cash Position: 273711000.00
PACS cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -67714000.00
PACS cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 127987000.00
PACS cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of Business: -131000.00
PACS income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 112315000.00
PACS balance_sheet (quarterly, 2026-03-31) — Goodwill: 61791000.00
PACS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 68061000.00
PACS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 4386758000.00
PACS income_statement (quarterly, 2026-03-31) — Gross Profit: 250427000.00
PACS cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 325000.00
PACS income_statement (quarterly, 2026-03-31) — Interest Expense: 6424000.00
PACS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 6424000.00
PACS cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 9099000.00
PACS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 1330368000.00
PACS cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -126961000.00
PACS cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 45000000.00
PACS balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 97025000.00
PACS balance_sheet (quarterly, 2026-03-31) — Leases: 136645000.00
PACS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 2888283000.00
PACS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 284814000.00
PACS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 3173097000.00
PACS cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 45000000.00
PACS cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -101439000.00
PACS balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 138713000.00
PACS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 5021000.00
PACS income_statement (quarterly, 2026-03-31) — Minority Interests: 27000.00
PACS balance_sheet (quarterly, 2026-03-31) — Net Debt: 45218000.00
PACS income_statement (quarterly, 2026-03-31) — Net Income: 80695000.00
PACS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 80695000.00
PACS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 80668000.00
PACS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 80695000.00
PACS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 80695000.00
PACS cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 80668000.00
PACS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 80668000.00
PACS income_statement (quarterly, 2026-03-31) — Net Interest Income: -6424000.00
PACS cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -20050000.00
PACS cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -56439000.00
PACS cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -56439000.00
PACS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -6424000.00
PACS cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -11275000.00
PACS balance_sheet (quarterly, 2026-03-31) — Net PPE: 4216071000.00
PACS cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -108348000.00
PACS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 969108000.00
PACS balance_sheet (quarterly, 2026-03-31) — Non Current Accrued Expenses: 208948000.00
PACS balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 107323000.00
PACS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 138237000.00
PACS income_statement (quarterly, 2026-03-31) — Normalized Income: 80695000.00
PACS cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 236335000.00
PACS cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -586000.00
PACS income_statement (quarterly, 2026-03-31) — Operating Income: 120035000.00
PACS income_statement (quarterly, 2026-03-31) — Operating Revenue: 1419959000.00
PACS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 157165029.00
PACS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 86904000.00
PACS balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 8385000.00
PACS income_statement (quarterly, 2026-03-31) — Other Gand A: 112315000.00
PACS income_statement (quarterly, 2026-03-31) — Other Income Expense: 125000.00
PACS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 6270000.00
PACS cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 12151000.00